Scholarlink

Background <p>Metabolic syndrome (MetS) is a constellation of cardio-metabolic risk factors that predispose individuals to cardiovascular disease and type 2 diabetes. However, the current prevalence of MetS in Malaysia is unknown. Thus, we aimed to determine the prevalence of MetS and its associated factors among the adult population in Malaysia.</p> Methods <p>This was a nationwide community-based cross-sectional study in Malaysia with two-stage stratified random sampling in 2023. MetS was defined based on the Harmonised Joint Interim Statement that required ≥ 3 metabolic risk abnormalities: abdominal obesity, elevated blood glucose, blood pressure, triglycerides, and low HDL-cholesterol. Complex sample analyses, including multiple binary logistic regression, were used to achieve the study objectives.</p> Results <p>The overall response rate was 71.4%, with 1,035 participants. The prevalence of MetS was 35.9% (95% CI: 31.4–40.6), translating to 8.5&#xa0;million people in Malaysia. The prevalence of abdominal obesity, elevated blood glucose, elevated blood pressure, elevated triglycerides, and low HDL-cholesterol were 52.8%, 21.5%, 43.4%, 33.4%, and 44.6%, respectively. Increasing age groups, Indian ethnicity (aOR: 2.24, 95% CI: 1.19–4.22), elevated aspartate aminotransferase (aOR: 3.09, 95% CI: 1.50–6.35), and elevated gamma glutamyl-transferase (aOR: 3.30, 95% CI: 1.84–5.92) were independent factors associated with MetS.</p> Conclusions <p>MetS is highly prevalent in Malaysia and represents a pressing public health issue. Concerted multisectoral strategies are needed to manage this epidemic, and precise public health interventions can be targeted at the identified high-risk subpopulations for more effective and efficient outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The prevalence of metabolic syndrome and the associated factors in a multiethnic upper-middle-income country in Asia: findings from a nationwide community-based study in 2023

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月22日

查看全文
  • Kim Sui Wan,
  • Muhammad Fadhli Mohd Yusoff,
  • Halizah Mat Rifin,
  • Wah Kheong Chan,
  • Kishwen Kanna Yoga Ratnam,
  • Shubash Shander Ganapathy,
  • Hamizatul Akmal Abd Hamid,
  • Masni Mohamad,
  • Nurain Mohd Noor,
  • Feisul Mustapha,
  • Noor Ani Ahmad

摘要

Background

Metabolic syndrome (MetS) is a constellation of cardio-metabolic risk factors that predispose individuals to cardiovascular disease and type 2 diabetes. However, the current prevalence of MetS in Malaysia is unknown. Thus, we aimed to determine the prevalence of MetS and its associated factors among the adult population in Malaysia.

Methods

This was a nationwide community-based cross-sectional study in Malaysia with two-stage stratified random sampling in 2023. MetS was defined based on the Harmonised Joint Interim Statement that required ≥ 3 metabolic risk abnormalities: abdominal obesity, elevated blood glucose, blood pressure, triglycerides, and low HDL-cholesterol. Complex sample analyses, including multiple binary logistic regression, were used to achieve the study objectives.

Results

The overall response rate was 71.4%, with 1,035 participants. The prevalence of MetS was 35.9% (95% CI: 31.4–40.6), translating to 8.5 million people in Malaysia. The prevalence of abdominal obesity, elevated blood glucose, elevated blood pressure, elevated triglycerides, and low HDL-cholesterol were 52.8%, 21.5%, 43.4%, 33.4%, and 44.6%, respectively. Increasing age groups, Indian ethnicity (aOR: 2.24, 95% CI: 1.19–4.22), elevated aspartate aminotransferase (aOR: 3.09, 95% CI: 1.50–6.35), and elevated gamma glutamyl-transferase (aOR: 3.30, 95% CI: 1.84–5.92) were independent factors associated with MetS.

Conclusions

MetS is highly prevalent in Malaysia and represents a pressing public health issue. Concerted multisectoral strategies are needed to manage this epidemic, and precise public health interventions can be targeted at the identified high-risk subpopulations for more effective and efficient outcomes.